Microbial Lipase Market Size & Share 2026-2035

Microbial Lipase Market Size

The microbial lipase market was valued at USD 671.8 million in 2025, is valued at USD 716.4 million in 2026, and is projected to reach USD 1.3 billion by 2035, expanding at approximately 6.5% CAGR during 2026–2035.

Microbial lipases are triacylglycerol acyl hydrolases that cleave ester bonds at oil-water interfaces and can also catalyze esterification, transesterification, interesterification, acidolysis, and alcoholysis reactions ^{[1]Springer Nature / Microbial Cell Factories - link.springer.com}. Their commercial utility rests on this dual role: the same enzyme class can remove triglyceride soils from fabric, release flavor-active fatty acids in dairy matrices, generate emulsifying lipids in dough, or produce chiral intermediates and specialty esters under relatively mild conditions.

Fungal, bacterial, and yeast systems provide distinct production and performance profiles. Filamentous fungi are attractive industrial hosts because many secrete lipases extracellularly, reducing recovery complexity relative to intracellular production routes ^{[2]Frontiers in Microbiology - frontiersin.org}. Bacterial lipases contribute alkaline tolerance and detergent compatibility, while yeast-derived preparations are valued for stereoselectivity in specialty synthesis and structured-lipid applications. This source diversity allows enzyme suppliers to optimize formulations around substrate type, wash conditions, food-processing requirements, or solvent exposure rather than relying on a single catalytic platform.

Demand is anchored in cleaning agents, but the market's growth base extends into animal nutrition, dairy flavor development, bakery processing, cosmetics, textile and leather processing, pulp and paper, and selected biofuel applications. The central commercial question is whether suppliers can preserve enzyme performance while lowering cost per unit of catalytic activity. That question is most acute in commodity biodiesel and bulk oleochemical processing, where conventional alkali catalysts retain a substantial cost advantage.

Cost remains the dividing line between premium and volume-led opportunities. In pharmaceutical synthesis, specialty dairy, and high-performance cleaning, enzyme cost can be justified by selectivity, formulation value, or regulatory positioning. In biodiesel and other bulk conversion processes, the economics remain dependent on improved reuse, immobilization, fermentation yield, and downstream recovery. Suppliers that combine application support with scalable production are therefore better placed than suppliers competing only on enzyme activity specifications.

The market scope covers fermentation-derived microbial lipases supplied in liquid and powder forms across fungi, bacteria, and yeast sources. Applications include cleaning agents, animal feed, dairy products, bakery products, confectionery products, pharmaceuticals and nutraceuticals, cosmetics and personal care, biofuel and biodiesel production, textile and leather processing, pulp and paper, and other specialty uses. The analysis covers 2022–2035, with 2025 as the base year and 2026–2035 as the forecast period, across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Drivers

Detergent reformulation is the market's largest demand engine. Lipases hydrolyze fatty soils such as sebum, cooking oil, and cosmetic residues, making those residues easier for surfactant systems to disperse during washing. The value proposition becomes stronger in cold-water cycles, where reduced thermal energy limits the cleaning contribution available from temperature alone. BASF introduced Lavergy L Pace, a liquid lipase positioned for fat and oil stain removal at low temperatures, in July 2025 as part of its completed liquid enzyme portfolio for laundry and cleaning applications ^{[3]BASF - basf.com}. This product activity illustrates continued investment in liquid, multi-enzyme detergent systems rather than a return to surfactant-only formulations.

Dairy processors use lipases to control the release of fatty acids that shape cheese flavor. In enzyme-modified cheese, lipase and protease systems compress portions of the maturation process into a controlled manufacturing step, allowing flavor ingredients to be produced with more predictable intensity than conventional aging alone. Microbial alternatives are particularly relevant where processors require non-animal enzyme options for vegetarian, halal, or kosher positioning. Novonesis introduced SpiceIT M100 in 2024 as a microbial lipase designed to provide animal-style flavor notes in cheese applications ^{[4]Novonesis - novonesis.com}.

Bakery demand is supported by lipases that generate surface-active lysophospholipids from flour lipids during dough processing. These in-situ emulsifying compounds can improve dough handling, gas retention, crumb structure, and loaf volume while reducing reliance on conventional chemical emulsifiers. Regulatory clearances have expanded the available source-organism base. The U.S. Food and Drug Administration issued a "no questions" letter for GRN 1154 covering a triacylglycerol lipase preparation for baking use in August 2024, while Food Standards Australia New Zealand approved a triacylglycerol lipase from a genetically modified Trichoderma reesei strain for baking and cereal processing in the same year.

Animal nutrition is another material growth route because lipid digestion can be a limiting factor in young poultry and swine. Supplemental lipases can improve utilization of dietary fats where endogenous digestive capacity and bile secretion are still developing. The commercial implication is broader than feed conversion alone: improved fat digestion can give nutritionists more flexibility to use alternative energy inputs while maintaining formulation targets.

Textile, leather, pulp, and paper applications are advancing from a smaller base because lipases can reduce the use of aggressive chemical treatments. Enzymatic degreasing can remove lipid residues from hides and fibers under milder operating conditions, while pulp and paper applications target pitch-forming triglycerides and waxes that foul production equipment. Adoption depends on site-level process validation, but environmental compliance and wastewater-management pressures are increasing the relative attractiveness of enzyme-assisted processing.

Key Restraints

Production economics remain the principal restraint. Fermentation inputs, recovery, purification, stabilization, and immobilization add cost before the enzyme reaches an end user. In industrial synthesis, immobilized lipase cost can represent a substantial share of manufacturing cost, especially where the catalyst cannot be reused for enough cycles to offset its initial price. This leaves chemical catalysts better positioned in price-sensitive processes with low tolerance for catalytic premiums.

Industrial operating conditions can also limit enzyme lifetime. High temperatures, alkaline pH, oxidants, methanol, shear, and certain metal ions can reduce lipase activity or shorten usable life. Immobilization can improve stability and allow reuse, but it introduces carrier costs and process-development requirements. The technical challenge is therefore not simply identifying an active lipase; it is maintaining activity within a specific detergent, biodiesel, textile, or food-processing environment.

Food-enzyme approvals create an additional barrier for new source organisms. Regulation (EC) No 1332/2008 requires food enzymes placed on the European Union market to undergo the relevant authorization process. EFSA continues to evaluate food-enzyme applications, and the evolving authorization environment can complicate launch planning for suppliers selling across multiple jurisdictions. Smaller producers may face a disproportionate burden because they must build technical dossiers and navigate country-specific requirements without the regulatory infrastructure of global enzyme companies.

Emerging markets can offer substantial volume potential but may lack local application laboratories, distributor technical teams, or end-user expertise needed to optimize dosage, temperature, pH, and compatibility. This slows adoption in applications where a lipase is not a simple drop-in replacement for a chemical input. Suppliers that provide formulation support and on-site validation can reduce that barrier, although the associated service model increases the cost of market development.

By contrast, biodiesel and bulk oleochemicals expose the market's economic boundary. Lipases can handle high-free-fatty-acid feedstocks and operate under mild conditions, but chemical catalysts retain an advantage where throughput and catalyst cost dominate the purchase decision. The competitive payoff from protein engineering, immobilization, and efficient fermentation will therefore be greatest when those advances lower delivered cost rather than merely improve laboratory activity.

Microbial Lipase Market Segment Analysis

By Source

Fungi

Fungal lipases represented USD 251.9 million in 2025 and are projected to reach USD 484.0 million by 2035 at approximately 6.74% CAGR. Their leading position reflects the industrial advantages of extracellular secretion and broad operating utility. Aspergillus, Rhizopus, Penicillium, Mucor, Rhizomucor, and Thermomyces species supply lipases used in detergents, bakery products, dairy flavor, structured lipids, and industrial processing.

Fungal lipases are particularly relevant where manufacturers need robust activity alongside economical downstream recovery. In baking, regioselective preparations can generate lysophospholipids that improve dough structure. In pulp processing, lipases can hydrolyze pitch-forming lipid fractions that would otherwise contribute to deposits on production equipment, ^{[5]MDPI Microorganisms - mdpi.com}. Their value is therefore linked to process integration, not simply enzyme volume.

Bacteria

Bacterial lipases were valued at USD 245.2 million in 2025 and are expected to reach USD 471.3 million by 2035, also expanding at approximately 6.74% CAGR. Their importance is concentrated in alkaline and detergent-compatible environments. Lipases from genera including Pseudomonas and Bacillus can exhibit tolerance to detergent components, elevated pH, and temperature variation, supporting their use in laundry, institutional cleaning, and selected industrial conversion processes.

This category benefits from the shift toward low-temperature washing because formulators require enzymes that retain practical activity in complex liquid and powder detergent matrices. The commercial opportunity is strongest for suppliers able to demonstrate compatibility with surfactants, oxidants, and other enzymes used in multi-enzyme systems.

Yeast

Yeast-derived lipases accounted for USD 174.7 million in 2025 and are projected to reach USD 312.7 million by 2035 at approximately 5.99% CAGR. Their lower projected growth rate reflects maturity in high-value niches rather than diminished relevance. Candida antarctica lipase B is widely used in immobilized form for esterification, transesterification, and enantioselective synthesis, while Candida rugosa lipase remains important in dairy flavor applications ^{[6]MDPI Catalysts - mdpi.com}.

Yeast lipases are less exposed to commodity pricing because stereoselectivity and substrate specificity can be difficult to replace with conventional catalysts. That characteristic supports their role in pharmaceutical intermediates, specialty oleochemicals, cosmetic esters, and carefully controlled dairy applications.

By Form

Liquid

Liquid products represented 51% of the market in 2025, equivalent to USD 342.6 million, and are projected to reach USD 646.7 million by 2035. Their principal advantage is compatibility with aqueous manufacturing streams. Liquid lipases can be dosed directly into detergent bases, dairy systems, and other continuous processes, avoiding an additional dissolution step and enabling precise volumetric addition.

The form's importance is especially apparent in home-care products, where detergent producers increasingly use liquid enzyme concentrates that can be blended into finished formulations. BASF's launch of a liquid lipase for low-temperature laundry cleaning reinforces the commercial relevance of this format in the largest application category.

Powder

Powder lipases generated USD 329.2 million in 2025 and are projected to reach USD 621.3 million by 2035. They remain important in bakery premixes, animal feed, dry detergent formulations, and logistics-sensitive supply chains because they offer storage stability and lower transport weight. However, feed and dry-blend uses require sufficient protection against heat, moisture, and handling losses.

The powder category is therefore shaped by formulation technology. Encapsulation, thermostable strains, and coating systems can determine whether a preparation maintains useful activity through feed pelleting or dry-mix storage. Suppliers able to preserve activity through these conditions can access applications where liquid handling is impractical.

By Application

Cleaning Agents

Cleaning agents remain the largest application, rising from USD 263.5 million in 2025 to USD 506.3 million by 2035 at approximately 6.74% CAGR. Lipases complement surfactants by converting triglyceride soils into more dispersible components during washing. Their value is highest in cold-water and short-cycle formulations, where enzymes can compensate for lower thermal input.

The segment is also commercially attractive because lipases are rarely sold as isolated inputs. They are incorporated into broader enzyme systems that can include proteases, amylases, cellulases, and mannanases, creating opportunities for application-specific formulation support and differentiated product positioning.

Animal Feed

Animal feed is projected to increase from USD 88.1 million in 2025 to USD 170.7 million by 2035 at approximately 6.84% CAGR. Exogenous lipases can improve the utilization of dietary fat in poultry, swine, and aquaculture systems where digestive capacity or feed composition creates a performance constraint. The purchasing rationale is economic: improved fat utilization can allow feed producers to manage energy density and ingredient flexibility without compromising targeted animal performance.

Dairy Products

The dairy segment is expected to grow from USD 80.9 million in 2025 to USD 154.5 million by 2035. Lipases enable controlled hydrolysis of milk fat, releasing fatty acids associated with the flavor profiles of aged and specialty cheeses. Enzyme-modified cheese production converts this functionality into a manufacturing advantage by accelerating development of targeted flavor intensity.

This application rewards precision rather than sheer enzyme volume. A lipase that produces a consistent flavor profile can reduce variability in processed cheese and savory ingredient production, while microbial alternatives can widen options for products requiring non-animal certification.

Bakery Products

Bakery applications are projected to rise from USD 53.9 million in 2025 to USD 102.6 million by 2035. Lipases act on endogenous flour lipids to generate compounds that improve dough stability and bread texture, allowing some formulations to reduce reliance on conventional emulsifiers. Product approvals and clean-label formulation strategies will remain important demand variables, particularly in industrial bread and frozen-dough production.

dsm-firmenich markets Panamore lipase solutions as alternatives to selected chemical emulsifiers in bakery products, demonstrating how lipases are being positioned as both functional and formulation-oriented inputs.

Confectionery Products

Confectionery applications are projected to reach USD 64.3 million by 2035 from USD 38.9 million in 2025. Lipases can support enzymatic interesterification used to produce cocoa-butter equivalents and other structured fats with specified melting characteristics. Their contribution is most relevant where manufacturers need controlled triglyceride composition rather than a broadly reactive chemical catalyst.

Pharmaceuticals & Nutraceuticals

Pharmaceuticals and nutraceuticals are projected to increase from USD 32.2 million in 2025 to USD 51.6 million by 2035. Lipases are used as enantioselective catalysts in synthesis routes that require selective hydrolysis or esterification of chiral compounds. In nutraceutical manufacturing, they can support the production of structured lipids and processing of fat-soluble ingredients.

Although this segment has a lower forecast CAGR than the overall market, it carries high value density. Qualification requirements, product consistency, and regulatory documentation raise switching costs for end users, making specialized supplier relationships particularly important.

Cosmetics & Personal Care

Cosmetics and personal care are projected to grow from USD 47.6 million in 2025 to USD 93.5 million by 2035 at approximately 6.97% CAGR. Microbial lipases are used to synthesize specialty esters, emollients, and fragrance-related ingredients under milder processing conditions than certain conventional chemical routes. The segment benefits from demand for ingredients associated with bio-based or lower-impact manufacturing narratives, provided suppliers can substantiate performance and consistency.

Biofuel & Biodiesel Production

Biofuel and biodiesel applications are expected to increase from USD 25.4 million in 2025 to USD 38.9 million by 2035. Lipase-catalyzed reactions can convert triglycerides and free fatty acids under mild conditions and can be useful for feedstocks that are difficult to process through conventional alkali routes. However, enzyme cost, methanol tolerance, and reuse requirements keep this application below the overall market growth rate.

Textile & Leather Processing

Textile and leather processing is the fastest-growing application, projected to expand from USD 20.9 million in 2025 to USD 43.9 million by 2035 at approximately 7.71% CAGR. Lipases can remove oils and fats from fibers and hides while reducing dependence on solvent-intensive degreasing steps. The growth outlook reflects the combination of environmental pressure and the operational value of improved wettability, dye uptake, and wastewater management.

Pulp & Paper

Pulp and paper demand is projected to increase from USD 13.7 million in 2025 to USD 27.7 million by 2035. Lipases target pitch components such as triglycerides and waxes that can form deposits on processing equipment. Their adoption is linked to mill-specific deposit-control economics, including avoided downtime and lower chemical-treatment demand.

Others

Other applications, projected to grow from USD 6.9 million in 2025 to USD 13.9 million by 2035, include specialty oleochemical conversion, biosensor development, bioremediation, and selected wastewater-treatment uses. These niches are small in aggregate but can be commercially relevant where lipase selectivity provides a solution unavailable through general-purpose chemical treatment.

The fastest-growing applications are also those in which the enzyme substitutes for a difficult chemical processing step rather than merely adding incremental performance. Textile and leather processing, pulp and paper, and selected cosmetic ester applications gain from lower chemical intensity, process specificity, or improved environmental handling. Biofuel remains the major exception: its technical case is credible, but its economic case will remain limited until catalyst reuse and production costs improve materially.

Microbial Lipase Market Regional Analysis

North America

North America accounted for USD 218.3 million in 2025 and is projected to reach USD 420.6 million by 2035 at approximately 6.77% CAGR. The region combines large detergent and institutional-cleaning markets with specialty dairy manufacturing, pharmaceutical synthesis, animal nutrition, and high-value personal-care demand. Regulatory pathways also influence the region's relevance to global suppliers because food-enzyme approvals in the United States and Canada can support subsequent commercialization strategies in other markets.

The FDA issued "no questions" letters for several lipase-related GRAS notifications, including GRN 1154 for a baking enzyme preparation and GRN 1161 for Meito Sangyo's triacylglycerol lipase preparation for multiple food applications ^{[7]U.S. Food and Drug Administration - hfpappexternal.fda.gov}. These actions reduce uncertainty for the covered products, although each approval remains specific to the relevant preparation and intended use.

Canada is a meaningful food-enzyme market because Health Canada has authorized specified lipase uses from multiple microbial sources under its permitted-food-enzyme framework ^{[8]Health Canada - canada.ca}. This creates opportunities in bakery, dairy, and processed-food applications where ingredient suppliers require a defined regulatory basis before product launch.

Europe

Europe is projected to grow from USD 124.3 million in 2025 to USD 243.1 million by 2035 at approximately 6.92% CAGR, the highest regional rate in the market. Its demand is supported by industrial bakery, dairy, home care, pharmaceutical, and specialty-ingredient manufacturing. Germany, France, Italy, Spain, and the United Kingdom collectively provide a concentration of food-processing capability, enzyme know-how, and premium applications.

European growth contains a regulatory tension. Regulation (EC) No 1332/2008 established the framework for food-enzyme authorization, while EFSA continues its role in evaluating food-enzyme applications. For enzyme suppliers, this means the region can offer high-value demand but requires disciplined dossier development and market-access planning. The same rigor that slows some launches can become a barrier to entry once approvals and customer qualifications are secured.

Asia Pacific

Asia Pacific is the largest regional market, valued at USD 251.9 million in 2025 and projected to reach USD 484.0 million by 2035. The region is both a major production base for microbial enzymes and a high-growth consumption market for food processing, detergent manufacturing, animal feed, textiles, leather, and personal care.

China's relevance stems from manufacturing scale and domestic demand across food, home-care, and industrial-processing sectors. India combines expanding dairy, feed, and industrial-biotechnology demand with a growing domestic enzyme supplier base. Advanced Enzyme Technologies reported consolidated revenue of ₹6,239 million in fiscal year 2023–24, with a 33% EBITDA margin and exports representing approximately 31% of revenue. Aumgene Biosciences reports fermentation capacity exceeding 100 m³ and offers lipase preparations for food, feed, textile, paper, detergent, and related applications.

Japan remains important in specialty ingredients and precision biocatalysis. Amano Enzyme supplies lipase products for structured lipids, dairy flavors, oil processing, and pharmaceutical applications. Meito Sangyo's U.S. GRAS clearance for its lipase preparation reflects how Japanese enzyme companies are combining specialized product portfolios with regulatory expansion beyond their domestic market.

Australia and New Zealand contribute through food processing, dairy, and animal nutrition, supported by FSANZ approvals for food-processing aids. The approval of a triacylglycerol lipase from genetically modified Trichoderma reesei for baking and cereal processing demonstrates continuing regulatory engagement with new enzyme products in the region.

Latin America

Latin America accounted for USD 42.7 million in 2025 and is projected to reach USD 69.5 million by 2035 at approximately 5.00% CAGR. Brazil, Mexico, and Argentina provide the region's principal demand bases through animal protein production, food processing, cleaning products, and selected biofuel-related uses.

The region's slower forecast growth reflects price sensitivity in feed, biodiesel, and industrial-processing applications. Imported enzyme products can face higher delivered costs, and chemical alternatives remain attractive where environmental-compliance requirements are less stringent or where technical support for enzyme optimization is limited. Suppliers that can demonstrate feed-cost savings, improved processing yield, or reduced waste-management burden are more likely to overcome these constraints.

Middle East & Africa

The Middle East & Africa market is expected to increase from USD 34.6 million in 2025 to USD 50.9 million by 2035 at approximately 3.92% CAGR. Demand is concentrated in poultry and animal feed, institutional cleaning, food processing, and selected premium food and personal-care applications.

Saudi Arabia and the United Arab Emirates offer opportunities in commercial food service, poultry production, and premium consumer products, while South Africa provides an established food-processing and feed base. Across much of Sub-Saharan Africa, however, adoption is constrained by cost, limited application support, and a less developed domestic biotechnology manufacturing infrastructure. Growth will depend less on broad awareness campaigns than on practical demonstrations that establish a clear return from enzyme use in local processing conditions.

This creates a strategic advantage for suppliers that can operate across both models: maintain regulatory and technical credibility in North America and Europe while building cost-competitive manufacturing, customer service, and application-development capacity in Asia Pacific. Latin America and the Middle East & Africa will remain more sensitive to delivered enzyme cost and local technical support, making cost reduction and distributor capability more important than product breadth alone.

Microbial Lipase Market Share & Competitive Landscape

Competition spans global enzyme groups with multi-application portfolios and specialist producers focused on dairy, bakery, structured lipids, or custom biocatalysis. Novonesis, IFF, dsm-firmenich, and BASF have broad application reach and the resources to combine strain development, formulation, regulatory affairs, and customer application support. Smaller and specialized companies compete through niche expertise, regional manufacturing, specific product portfolios, or custom-development capability.

Novonesis was created through the completed merger of Novozymes and Chr. Hansen in January 2024 ^{[9]Novonesis - novonesis.com}. The company's 2024 annual report identifies its reach across more than 30 industries and describes the launch of SpiceIT M100 for cheese-flavor applications. Its scale matters in microbial lipases because the market increasingly rewards suppliers able to integrate enzyme discovery with customer-specific application development.

IFF serves fabric care, food, and nutrition applications through a broader enzyme portfolio. Its laundry enzyme offering includes lipase solutions for fatty stains in stressed wash conditions. In October 2025, IFF and BASF announced a strategic collaboration intended to accelerate development of enzymatic biomaterials and next-generation technologies for fabric, dish, personal-care, and industrial-cleaning applications.

BASF's lipase positioning is concentrated in laundry, cleaning, and animal nutrition. Its July 2025 launch of Lavergy L Pace expanded its liquid laundry-enzyme portfolio and reinforces the importance of low-temperature cleaning performance in competitive formulation strategies. dsm-firmenich addresses bakery and oils-and-fats applications through products including the Panamore range, which it positions as a route to replace selected conventional emulsifiers in bakery products.

Advance Enzymes combines Indian manufacturing reach with food, feed, textile, healthcare, and biocatalysis operations. Amano Enzyme retains a specialized role in structured lipids, oil processing, dairy flavor, and pharmaceutical biocatalysis. Meito Sangyo supplies lipase products for flavor, food, cosmetics, diagnostics, and pharmaceutical-intermediate applications and has expanded food-use credentials through its U.S. GRAS notification.

Aumgene Biosciences participates through fermentation, contract services, and a portfolio spanning detergent, food, feed, and oil-and-fat applications. Bio Catalyst Ltd, Creative Enzymes, and SternEnzym occupy specialized positions in the competitive scope, including enzyme discovery, catalog supply, and food-enzyme systems. SternEnzym focuses on bakery, dairy, and confectionery enzyme applications, including products for dough conditioning and cheese-flavor development.

The competitive differentiator is increasingly the ability to supply a validated solution rather than an undifferentiated enzyme. Suppliers must demonstrate performance in a customer's formulation, protect activity during storage and processing, address regulatory documentation, and provide a credible cost-in-use case. This favors firms with application laboratories and regulatory depth, while leaving room for specialists that can offer distinctive catalytic properties or focused customer support.

Recent Industry Developments

Novonesis completed the merger of Novozymes and Chr. Hansen on January 29, 2024. The combination was completed following required regulatory clearances and registration with the Danish Business Authority.

Novonesis launched SpiceIT M100 in April 2024. The product was introduced as a microbial lipase designed to create animal-style flavor notes in cheese applications, supporting vegetarian, halal, and kosher formulation options.

The FDA issued a "no questions" letter for GRN 1154 on August 15, 2024. The notice covered a triacylglycerol lipase preparation produced by Komagataella phaffii for baking applications.

FSANZ approved Application A1284 on August 7, 2024. The approval covered triacylglycerol lipase from a genetically modified Trichoderma reesei strain as a processing aid for baking and cereal-based processes.

The FDA issued a "no questions" letter for GRN 1161 on September 24, 2024. The notice covered Meito Sangyo's triacylglycerol lipase preparation for specified cheese, edible-oil, brewing, flavoring, and baking uses.

BASF launched Lavergy L Pace on July 10, 2025. The liquid lipase was introduced for improved fat and oil stain removal at low wash temperatures as part of BASF's expanded liquid enzyme offering for laundry and cleaning.

BASF and IFF announced a strategic collaboration on October 21, 2025. The collaboration is intended to accelerate development of enzymatic biomaterials and technologies for fabric, dish, personal-care, and industrial-cleaning applications.